The Scientist

» E. coli and disease/medicine

Most Recent

image: Pleasant to the Touch

Pleasant to the Touch

By | September 1, 2012

Scientists hope an understanding of nerve fibers responsive only to gentle touch will give insight into the role the sense plays in social bonding.


image: Opinion: Younger Is Better

Opinion: Younger Is Better

By | August 31, 2012

Stem cells collected from younger donors are more effective for transplantation and regenerative medicine than those from older individuals.


image: Dieting Monkeys Don't Live Longer

Dieting Monkeys Don't Live Longer

By | August 29, 2012

The latest news from a long-term study of calorie restriction in rhesus macaques shows better health, but no boost in lifespan, in monkeys who eat less.


image: Epigenetic Drug Improves Cholesterol Levels

Epigenetic Drug Improves Cholesterol Levels

By | August 28, 2012

Results from a Phase II trial for cardiovascular disease with an epigenetic target therapy show promise.

1 Comment

image: Clinical Trial Misfortune

Clinical Trial Misfortune

By | August 28, 2012

A human trial of a hepatitis C treatment is shut down after one of the participants died.

1 Comment

image: Second Victim of Hantavirus

Second Victim of Hantavirus

By | August 28, 2012

Another person has died from the rodent-borne disease after visiting Yosemite National Park.


image: Texan West Nile Concerns

Texan West Nile Concerns

By | August 27, 2012

Researchers consider the recent reappearance of West Nile virus in Texas and the efforts to control it.


image: Blood Spots Are Epigenetic Time Capsules

Blood Spots Are Epigenetic Time Capsules

By | August 22, 2012

Researchers show that blood spotted onto Guthrie cards, usually at birth, can be a high quality source of methylated DNA for long-term epigenetic studies.


image: Zoo Virus Swap

Zoo Virus Swap

By | August 17, 2012

A polar bear in a German zoo dies after contracting a virus normally found in zebras.


image: Pharma Whistleblower

Pharma Whistleblower

By | August 16, 2012

A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.

1 Comment


Popular Now

  1. Inside a Lab Mouse’s High-Fat Diet
  2. Antidepressant Exerts Epigenetic Changes
  3. How Gastric Bypass Can Kill Sugar Cravings
  4. Birth of the Skin Microbiome
    Daily News Birth of the Skin Microbiome

    The immune system tolerates the colonization of commensal bacteria on the skin with the aid of regulatory T cells during the first few weeks of life, a mouse study shows.

Horizon Discovery
Horizon Discovery
Life Technologies